Skip to contentA
Abbott Laboratories
A
ABTAbbott Laboratories Q1 2016 · 10-Q
Revenue$4.89B$4.89B−0.2% vs Q1 2015 Net Income$316.00M$316.00M−86.2% vs Q1 2015 EPS Diluted$0.21$0.21−86.1% vs Q1 2015 Gross Profit$2,601,000,000−2.2% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abbott Laboratories · CIK 1800 · Engraved from SEC EDGAR
Operating Cash Flow-$93,000,000N/M Free Cash Flowderived-$336,000,000N/M Margins · derivedGross margin53.2%−1.1 pt vs Q1 2015
Operating margin10.7%−1.7 pt vs Q1 2015
Net margin6.5%−40.3 pt vs Q1 2015
ended Mar 31, 2016 · filed May 4, 2016 · 34 d after period end